Sun Pharma Advanced Research Company has informed that the Company has received the approval of the Stock Exchange for reclassification of shares under regulation of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the re-classification of the shares held by the following promoter shareholders in the public category.
The above information is a part of company’s filings submitted to BSE.